Stockholders’ Equity and Capitalization - Narrative (Details)						1 Months Ended		2 Months Ended	12 Months Ended
	Dec. 15, 2022 USD ($)	Nov. 10, 2022 USD ($) shares	Mar. 02, 2022 shares	Sep. 29, 2021 USD ($) $ / shares shares	Jul. 26, 2021 USD ($) $ / shares shares	Sep. 30, 2021 shares	Jul. 31, 2021 shares	Sep. 27, 2021 USD ($) shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Nov. 17, 2022 $ / shares	Feb. 05, 2021 shares
Class of Stock [Line Items]
Common stock, shares authorized (in shares)									5,000,000,000			5,000,000,000
Preferred stock, shares authorized (in shares)									50,000,000			50,000,000
Proceeds from pre-funded warrant exercises | $									$ 1,967	$ 11,800
Common stock issuance costs | $									$ 0	$ 935,260
Common stock issued for services (in shares)		416,270,514	150,000
Restricted stock units | $	$ 1,333,333
Emerald Health Therapeutics Inc
Class of Stock [Line Items]
Common stock issuance costs | $		$ 25,511
Exchange ratio		1.95
September 2021 Financing
Class of Stock [Line Items]
Sale of stock, gross aggregate proceeds | $				$ 6,998,034
Term (Years)				5 years
September 2021 Financing | Common Stock
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)				58,111,112
Two Thousand And Twenty One Inducement And Financing
Class of Stock [Line Items]
Common stock issuance costs | $								$ 935,260
Net proceeds from the transaction | $								$ 6,062,774
2021 Inducement Warrants
Class of Stock [Line Items]
Warrants exercise (in shares)					21,166,667
Exercise price (in dollars per share) | $ / shares					$ 0.06				$ 0.15
Proceeds from pre-funded warrant exercises | $					$ 1,270,000
Term (Years)									5 years
2021 Inducement Warrants | July 2021 Inducement Warrants
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares					$ 0.15
Number of shares issued in transaction (in shares)					21,166,667		21,166,667
2021 Pre-Funded Warrants | September 2021 Financing
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares				$ 0.0001
Number of shares issued in transaction (in shares)				19,666,667
Sale price (in dollars per share) | $ / shares				$ 0.0899
2021 Common Stock Warrants
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares									$ 0.09
Term (Years)									5 years
2021 Common Stock Warrants | September 2021 Financing
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares				$ 0.09
Number of shares issued in transaction (in shares)				77,777,779
Sale price (in dollars per share) | $ / shares				$ 0.09
2022 Common Stock Warrants to Service Provider
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares									$ 0.04
Term (Years)									2 years
2022 Common Stock Warrants to Service Provider | Two Thousand And Twenty One Inducement And Financing
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)								6,926,112
Percentage of total shares of common stock and pre-funded warrants sold in offering								7.00%
Pre-Funded Warrants
Class of Stock [Line Items]
Warrants exercise (in shares)									19,666,667	11,800,000
Proceeds from pre-funded warrant exercises | $									$ 1,967	$ 11,800
Intrinsic value of warrant exercises | $									$ 1,178,033	$ 460,200
Warrant exercises (in shares)									19,666,667	11,800,000
Pre-Funded Warrants | September 2021 Financing
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)						19,666,667
Common Stock Warrants
Class of Stock [Line Items]
Warrants exercise (in shares)										116,666,668
Exercise price (in dollars per share) | $ / shares											$ 0.017
Proceeds from pre-funded warrant exercises | $										$ 6,999,999
Intrinsic value of warrant exercises | $										$ 8,764,967
Warrant exercises (in shares)										116,666,668
Common Stock Warrants | September 2021 Financing
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)						77,777,779